Research Article

Comparative Pharmacokinetic Study of 5 Active Ingredients after Oral Administration of Zuogui Pill in Osteoporotic Rats with Different Syndrome Types

Table 7

Pharmacokinetic parameters of the 5 compounds in rats after oral administration of Zuogui Pill extract and integrated pharmacokinetic parameters (n = 6).

CompoundsGroupst1/2(h)Tmax(h)Cmax(ng/mL)AUC0–t(hng/mL)AUC0–∞(hng/mL)CL_F_obs (mL/h/kg)MRT0–t(h)MRT0–∞(h)

Chlorogenic acidNormal8.17 ± 1.790.25 ± 0.00346.14 ± 63.99497.98 ± 34.72546.26 ± 38.80914.49 ± 64.885.46 ± 0.488.17 ± 1.46
Osteoporosis6.38 ± 1.960.26 ± 0.02279.27 ± 56.34435.76 ± 59.78489.67 ± 77.691036.09 ± 154.416.78 ± 0.689.72 ± 2.61
Yang-deficiency5.41 ± 1.840.25 ± 0.00430.29 ± 98.55263.13 ± 40.25284.31 ± 33.341767.90 ± 187.684.52 ± 1.466.56 ± 2.64
Yin-deficiency6.61 ± 3.840.25 ± 0.00353.83 ± 83.80218.55 ± 23.29225.89 ± 25.032223.36 ± 229.723.03 ± 0.384.10 ± 1.02

LoganinNormal4.51 ± 0.450.25 ± 0.0013508.61 ± 2029.8520134.29 ± 3958.7920523.97 ± 3947.05361.54 ± 73.024.58 ± 0.475.10 ± 0.41
Osteoporosis2.74 ± 0.960.25 ± 0.008381.77 ± 1123.4717912.12 ± 6898.1617998.56 ± 6945.75460.13 ± 196.924.91 ± 1.295.02 ± 1.34
Yang-deficiency5.62 ± 1.630.21 ± 0.0514.72 ± 1.3827.46 ± 4.8328.61 ± 4.91257023.69 ± 42243.405.50 ± 0.676.62 ± 0.49
Yin-deficiency3.75 ± 0.700.25 ± 0.0016025.83 ± 2787.5841028.61 ± 6356.2641727.10 ± 6203.34176.22 ± 32.936.51 ± 0.916.92 ± 0.98

MorronisideNormal3.66 ± 1.18 0.29 ± 0.101719.66 ± 410.022151.00 ± 498.882171.33 ± 509.452966.14 ± 684.643.41 ± 0.333.66 ± 0.48
Osteoporosis2.40 ± 0.510.26 ± 0.021109.11 ± 163.311724.77 ± 149.051741.55 ± 136.083553.71 ± 268.044.37 ± 0.434.51 ± 0.38
Yang-deficiency3.83 ± 0.640.19 ± 0.041450.08 ± 337.061726.42 ± 217.111750.35 ± 215.203562.14 ± 427.534.68 ± 0.245.03 ± 0.33
Yin-deficiency2.90 ± 0.650.24 ± 0.031752.12 ± 321.113764.53 ± 842.383782.41 ± 832.521700.88 ± 406.175.08 ± 0.745.21 ± 0.78

AucubinNormal5.97 ± 2.890.38 ± 0.1484.43 ± 32.22170.50 ± 64.82204.69 ± 68.611358.04 ± 638.525.38 ± 2.018.58 ± 2.71
Osteoporosis3.67 ± 0.780.17 ± 0.00102.55 ± 23.62116.40 ± 11.00155.64 ± 24.541592.72 ± 276.683.06 ± 0.125.62 ± 1.09
Yang-deficiency7.40 ± 1.680.25 ± 0.0095.99 ± 24.1948.33 ± 14.05111.33 ± 29.942328.79 ± 701.232.95 ± 0.3811.69 ± 1.31
Yin-deficiency8.68 ± 2.920.25 ± 0.00181.24 ± 30.66201.40 ± 32.43272.67 ± 70.63959.16 ± 279.317.32 ± 1.9214.14 ± 5.85

Protocatechuic aldehydeNormal10.87 ± 4.480.45 ± 0.1018.86 ± 3.6264.15 ± 10.30119.88 ± 32.93750.08 ± 184.835.14 ± 0.1715.85 ± 6.12
Osteoporosis12.01 ± 4.690.30 ± 0.0010.10 ± 1.9934.92 ± 2.3772.28 ± 21.641279.06 ± 400.345.52 ± 0.2117.76 ± 6.26
Yang-deficiency2.09 ± 0.890.25 ± 0.0711.38 ± 1.3124.70 ± 1.6928.68 ± 6.493031.25 ± 535.722.55 ± 0.183.50 ± 1.38
Yin-deficiency2.20 ± 0.830.17 ± 0.078.81 ± 1.6127.48 ± 3.1028.87 ± 2.692933.07 ± 265.583.24 ± 0.373.79 ± 0.79

IntegratedNormal4.51 ± 0.440.25 ± 0.0011927.33 ± 1782.6717749.62 ± 3510.2718091.33 ± 3477.17390.40 ± 78.844.57 ± 0.475.09 ± 0.40
Osteoporosis2.74 ± 0.950.25 ± 0.007474.98 ± 1002.6116439.99 ± 6012.3716516.89 ± 6056.71472.07 ± 192.414.77 ± 1.274.87 ± 1.32
Yang-deficiency3.91 ± 0.650.19 ± 0.041210.34 ± 269.751486.54 ± 179.091507.82 ± 177.633452.60 ± 389.824.51 ± 0.234.87 ± 0.33
Yin-deficiency3.79 ± 0.640.25 ± 0.0014669.30 ± 2504.1738171.03 ± 5606.5038810.41 ± 5480.02184.70 ± 32.396.39 ± 0.896.80 ± 0.94

and , according to a one-way ANOVA, versus osteoporosis rats.